Education
PhD Chemistry, MSc Organic Chemistry, BSc Chemistry, Post-doctoral studies Organic Chemistry
About Satish Jalisatgi
Dr. Satish S. Jalisatgi earned his Ph.D. in Chemistry from the University of Mumbai (formerly Bombay), India, where he investigated the chemical constituents and pharmacological activity of Indian medicinal plants.He received his B.S. in Chemistry and M.S. in Organic Chemistry also from the University of Mumbai. After completing his postdoctoral studies at University of California, Berkeley, and at University of California, Los Angeles (UCLA), in organometallic chemistry, Dr. Jalisatgi spent several years at the University of Missouri as Assistant Professor of Research – Radiology and Assistant Director of the Institute of Nano and Molecular Medicine. There he managed various multidisciplinary projects focused on exploration of biomedical and material science applications of polyhedral boranes and carboranes. One of the prominent multidisciplinary projects involved coordinating research efforts from chemistry, cell biology, veterinary medicine, and nuclear physics to develop a new treatment modality for cancer, Boron Neutron Capture Therapy (BNCT). Dr. Jalisatgi served as the president of the International Society of Neutron Capture Therapy from 2014 to 2016. He also served as a member of National Cancer Institute (NCI) BNCT study group. He has mentored several undergraduate students, post-doctoral researchers, and taught undergraduate chemistry courses. His work has resulted in over 50 journal articles, and he is a joint inventor on multiple patent applications. He is also a registered patent agent with the United States Patent Office (USPTO). His current research is focused on utilizing unique structural and electronic properties of icosahedral polyhedral boranes and carboranes coupled with computational molecular docking studies and nanotechnology approaches to develop small molecule therapeutics and nano-scale drug delivery platforms. These include highly tumor-selective therapeutics for BNCT; target-specific multifunctional drug delivery systems carrying diagnostic and therapeutic functions; and use of boranes and carboranes as pharmacophores.